+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Germany Animal Vaccine Market 2019-2025

  • PDF Icon


  • January 2020
  • Region: Germany
  • Orion Market Research Private Limited
  • ID: 4969037
Germany Animal Vaccine Market Size, Share & Trends Analysis Report, By Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Aquaculture Vaccines, Companion Animal Vaccines, and Other Animal Vaccines) By Technology (Live Attenuated Vaccine, Killed/Inactive Vaccine, Recombinant Vaccine, Vectored Vaccine, Subunit Vaccine, DNA Vaccine, Chimeric Vaccine, and Others) and Forecast, 2019-2025.

Germany animal vaccine market is estimated to grow at a CAGR of around 6.0% during the forecast period. Germany is one of the potential countries lying on the bay and is covered by rivers, lakes, ponds and other water bodies. Fisheries and aquaculture are an important source of food and is being significantly preferred by the residents of the country. Therefore, there is a considerable size of the aquaculture industry in the country, which contributes significantly to the growth of the market. There is a significant rise in the demand for seafood, including crocodile, fishes, and pawns, which increases the need for fish and aqua vaccines in the country. Enteric Redmouth (ERM) vaccine, Vibrio anguillarum vaccine, Furunculosis vaccine, Vibrio salmonicida vaccine, Combined Vibriosis/Furunculosis vaccine, IPN Virus vaccine, Pasteurella vaccine, Combined Pasteurella/Vibriosis vaccine, Vibriosis vaccine for cod, Shrimp Vibriosis vaccine and others are some of the fish vaccines being used in fisheries and aquaculture.

Key players in the Germany animal vaccine market include Zoetis, Inc., Elanco, Merck & Co., Inc., and Ceva Santé Animale. These players are adopting crucial strategies, such as mergers and acquisitions, product launches, and partnerships and collaborations to maintain their competitiveness and increase their market share. For instance, in May 2019, Ceva Santé Animale and IDT Biologika GmbH have entered into an agreement for Ceva to acquire veterinary biopharmaceutical portfolio and R&D activities of IDT. This will enable IDT to focus on the production of pharmaceuticals and human biotechnology vaccines for national and global markets. Ceva is planning to invest significantly to develop a new Global Swine Innovation Centre at IDT Research in Riems, Germany and IDT's existing Dessau site. This center is expected to reinforce the biological R&D capabilities of Ceva and will combine the expertise of both the company's research teams and advanced pipelines. As a result, this acquisition will offer strong growth potential for Ceva.

Research Methodology

The market study of the Germany animal vaccine market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report is intended for pharmaceuticals companies, veterinary companies, government organizations for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation
  • Germany Animal Vaccine Market Research and Analysis, By Type
  • Germany Animal Vaccine Market Research and Analysis, By Technology

The Report Covers
  • Comprehensive research methodology of the Germany animal vaccine market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regulations and other government policies impacting the Germany animal vaccine market.
  • Insights about market determinants which are stimulating the Germany animal vaccine market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Germany Animal Vaccine Market by Type
5.1.1. Porcine Vaccines
5.1.2. Poultry Vaccines
5.1.3. Livestock Vaccines
5.1.4. Aquaculture Vaccines
5.1.5. Companion Animal Vaccines
5.1.6. Other Animal Vaccines
5.2. Germany Animal Vaccine Market by Technology
5.2.1. Live Attenuated Vaccine
5.2.2. Killed/Inactive Vaccine
5.2.3. Recombinant Vaccine
5.2.4. Vectored Vaccine
5.2.5. Subunit Vaccine
5.2.6. DNA Vaccine
5.2.7. Chimeric Vaccine
5.2.8. Others
6. Company Profiles
6.1. AniCon Labor GmbH
6.2. Ceva Santé Animale
6.3. Elanco
6.4. Heska Corp.
6.5. Merck & Co., Inc.
6.6. Neogen Corp.
6.8. Vetoquinol S.A.
6.9. Virbac SA
6.10. Zoetis, Inc.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • AniCon Labor GmbH
  • Ceva Santé Animale
  • Elanco
  • Heska Corp.
  • Merck & Co., Inc.
  • Neogen Corp.
  • Vetoquinol S.A.
  • Virbac SA
  • Zoetis, Inc.